{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:02:39Z","timestamp":1767841359978,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["16dk0307027"],"award-info":[{"award-number":["16dk0307027"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["15K09859"],"award-info":[{"award-number":["15K09859"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.braindev.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T08:37:51Z","timestamp":1550565471000},"page":"501-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Expert consensus on pharmacotherapy for tic disorders in Japan"],"prefix":"10.1016","volume":"41","author":[{"given":"Yu","family":"Hamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Fujio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Kano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2019.02.003_b0005","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM\u20135). Washington, DC, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.braindev.2019.02.003_b0010","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.eurpsy.2009.10.003","article-title":"Tic disorders: administrative prevalence and co-occurrence with attention-deficit\/hyperactivity disorder in a German community sample","volume":"26","author":"Schlander","year":"2011","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.braindev.2019.02.003_b0015","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1469-8749.2000.tb00346.x","article-title":"An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries","volume":"42","author":"Freeman","year":"2000","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2019.02.003_b0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S2215-0366(14)00133-3","article-title":"A personal 35 year perspective on Gilles de la Tourette syndrome: assessment, investigations, and management","volume":"2","author":"Robertson","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.braindev.2019.02.003_b0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/jnp.2009.21.1.13","article-title":"The behavioral spectrum of Gilles de la Tourette syndrome","volume":"21","author":"Cavanna","year":"2009","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.braindev.2019.02.003_b0030","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jaac.2013.09.015","article-title":"American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders","volume":"52","author":"Murphy","year":"2013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.braindev.2019.02.003_b0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/070674371205700302","article-title":"Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy","volume":"57","author":"Pringsheim","year":"2012","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.braindev.2019.02.003_b0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"Guidelines Group: European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.braindev.2019.02.003_b0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hup.2498","article-title":"Aripiprazole for Tourette's syndrome: a systematic review and meta-analysis","volume":"31","author":"Zheng","year":"2016","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.braindev.2019.02.003_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20040","article-title":"Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis","volume":"20","author":"Hollis","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.braindev.2019.02.003_b0055","first-page":"988","article-title":"Practitioner Review: Treatments for Tourette syndrome in children and young people - a systematic review","volume":"57","author":"Whittington","year":"2016","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.braindev.2019.02.003_b0060","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejpn.2011.12.001","article-title":"Treatment practices in Tourette syndrome: the European perspective","volume":"16","author":"Rickards","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2019.02.003_b0065","first-page":"175","article-title":"Tic disorders and obsessive-compulsive disorder in childhood","volume":"54","author":"Kano","year":"2013","journal-title":"Japan J Child Adolescent Psychiatry"},{"key":"10.1016\/j.braindev.2019.02.003_b0070","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/jcpp.12592","article-title":"Commentary: Are alpha-2 agonist really effective in children with tics with comorbid ADHD? A commentary on Whittington et al. (2016)","volume":"57","author":"Bloch","year":"2016","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.braindev.2019.02.003_b0075","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jpsychires.2013.04.003","article-title":"Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: a naturalistic comparative study","volume":"47","author":"Masi","year":"2013","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.braindev.2019.02.003_b0080","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1089\/cap.2014.0128","article-title":"A promising preliminary study of aripiprazole for treatment-resistant childhood obsessive-compulsive disorder","volume":"25","author":"Ercan","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.braindev.2019.02.003_b0085","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1089\/cap.2017.0024","article-title":"Extended-release guanfacine does not show a large effect on tic severity in children with chronic tic disorders","volume":"27","author":"Murphy","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.braindev.2019.02.003_b0090","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaac.2015.06.011","article-title":"Meta-analysis: risk of tics associated with psychostimulant use in randomized, placebo-controlled trials","volume":"54","author":"Cohen","year":"2015","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760418304534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760418304534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:48:07Z","timestamp":1759952887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760418304534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0387760418304534"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2019.02.003","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expert consensus on pharmacotherapy for tic disorders in Japan","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}